Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.K. (FTSE) Medical Equipment Industry Analysis

UpdatedMar 19, 2026
DataAggregated Company Financials
Companies20
  • 7D0.02%
  • 3M-0.4%
  • 1Y5.2%
  • YTD0.7%

In the last week, Medical Equipment has been flat. As for the the longer term, the industry is up 3.9% over the past 12 months. As for the next few years, earnings are expected to grow by 16% per annum.

Industry Valuation and Performance

Has the U.K. Medical Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 19 Mar 2026UK£16.5bUK£7.2bUK£581.3m22.6x28.4x2.3x
Sat, 14 Feb 2026UK£17.1bUK£6.8bUK£496.4m29.1x34.4x2.5x
Mon, 12 Jan 2026UK£16.8bUK£6.9bUK£505.6m29.4x33.3x2.4x
Wed, 10 Dec 2025UK£16.3bUK£6.9bUK£501.7m26.5x32.5x2.4x
Fri, 07 Nov 2025UK£16.5bUK£7.0bUK£511.4m27.3x32.3x2.3x
Sun, 05 Oct 2025UK£17.8bUK£6.8bUK£492.7m29x36.2x2.6x
Tue, 02 Sep 2025UK£18.3bUK£6.8bUK£443.5m31.9x41.4x2.7x
Thu, 31 Jul 2025UK£16.3bUK£6.8bUK£393.8m42.1x41.5x2.4x
Sat, 28 Jun 2025UK£17.1bUK£6.6bUK£360.4m45.9x47.4x2.6x
Mon, 26 May 2025UK£16.5bUK£6.6bUK£368.6m36.8x44.7x2.5x
Wed, 23 Apr 2025UK£15.0bUK£6.7bUK£384.3m35.5x39.1x2.2x
Fri, 21 Mar 2025UK£16.3bUK£6.9bUK£404.5m33.1x40.2x2.4x
Sun, 16 Feb 2025UK£15.4bUK£6.8bUK£306.0m37.7x50.2x2.3x
Tue, 14 Jan 2025UK£14.6bUK£7.0bUK£318.0m35.2x45.9x2.1x
Thu, 12 Dec 2024UK£14.8bUK£6.7bUK£299.9m35.9x49.3x2.2x
Sat, 09 Nov 2024UK£13.9bUK£6.6bUK£295.2m32.8x46.9x2.1x
Mon, 07 Oct 2024UK£16.0bUK£6.5bUK£288.5m34.8x55.3x2.4x
Wed, 04 Sep 2024UK£16.8bUK£6.6bUK£294.0m39.5x57.1x2.6x
Fri, 02 Aug 2024UK£16.8bUK£6.7bUK£270.0m39.4x62.4x2.5x
Sun, 30 Jun 2024UK£15.0bUK£6.7bUK£251.0m38.6x59.6x2.2x
Tue, 28 May 2024UK£15.2bUK£6.6bUK£254.4m33.3x59.7x2.3x
Thu, 25 Apr 2024UK£15.5bUK£6.7bUK£248.1m38.5x62.6x2.3x
Sat, 23 Mar 2024UK£16.1bUK£6.6bUK£245.5m39.3x65.4x2.4x
Mon, 19 Feb 2024UK£15.9bUK£6.4bUK£147.9m47.9x107.5x2.5x
Wed, 17 Jan 2024UK£15.6bUK£6.5bUK£101.9m45.2x153.1x2.4x
Fri, 15 Dec 2023UK£15.7bUK£6.4bUK£99.4m48.6x157.5x2.4x
Sun, 12 Nov 2023UK£14.1bUK£6.7bUK£108.0m42.5x130.8x2.1x
Tue, 10 Oct 2023UK£13.9bUK£6.7bUK£91.8m47.2x151.2x2.1x
Thu, 07 Sep 2023UK£15.1bUK£6.5bUK£88.4m52.2x170.3x2.3x
Sat, 05 Aug 2023UK£15.8bUK£6.4bUK£86.4m57.6x183x2.5x
Mon, 03 Jul 2023UK£16.6bUK£6.3bUK£86.1m63x193.2x2.6x
Wed, 31 May 2023UK£16.2bUK£6.5bUK£92.1m58.9x175.7x2.5x
Fri, 28 Apr 2023UK£17.1bUK£6.4bUK£73.5m45.3x232.8x2.7x
Sun, 26 Mar 2023UK£15.6bUK£6.6bUK£98.1m24x159.5x2.4x
Price to Earnings Ratio

159.5x


Total Market Cap: UK£15.6bTotal Earnings: UK£98.1mTotal Revenue: UK£6.6bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Medical Equipment Industry Price to Earnings3Y Average 85.5x202420252026
Current Industry PE
  • Investors are pessimistic on the British Medical Equipment industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 28.6x which is lower than its 3-year average PE of 85.6x.
  • The industry is trading close to its 3-year average PS ratio of 2.4x.
Past Earnings Growth
  • The earnings for companies in the Medical Equipment industry have grown 81% per year over the last three years.
  • Revenues for these companies have grown 2.8% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market-0.77%
Healthcare-1.38%
Medical Equipment0.016%
Medical Equipment0.35%
Medical Supplies-0.69%
Industry PE
  • Investors are most optimistic about the Medical Supplies industry even though it's trading below its 3-year average PE ratio of 58.4x.
    • Analysts are expecting annual earnings growth of 22.4%, which is higher than its past year's earnings growth of 9.9% per year.
  • Investors are most pessimistic about the Medical Equipment industry, which is trading below its 3-year average of 128x.
Forecasted Growth
  • Analysts are most optimistic on the Medical Supplies industry, expecting annual earnings growth of 22% over the next 5 years.
  • This is better than its past earnings growth rate of 9.9% per year.
  • In contrast, the Medical Equipment industry is expected to see its earnings grow by 13% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SN. Smith & NephewUK£12.520.6%
+UK£68.0m		15.0%PE22.6x
AMS Advanced Medical Solutions GroupUK£1.962.3%
+UK£9.5m		-3.6%PE46.4x
TSTL TristelUK£3.880.6%
+UK£1.2m		12.3%PE23.6x
RUA RUA Life SciencesUK£0.147.5%
+UK£620.6k		15.2%PS2x

Latest News

CTEC
UK£2.34
Convatec Group
7D
-1.0%
1Y
-9.1%
SN.
UK£12.52
Smith & Nephew
7D
0.6%
1Y
15.0%

SN.: Product Rollout And Capital Returns Will Support Future Margin Progress

Analysts have trimmed their price target on Smith & Nephew slightly to £14.30 from £14.31, reflecting updated assumptions on discount rate, revenue growth, profit margin and future P/E that keep the overall valuation broadly unchanged. What's in the News Launch of ALLEVYN COMPLETE CARE Foam Dressing, a five layer wound dressing designed for both wound management and pressure injury prevention, with plans to roll out beyond the US into European and other international markets in 2026 (Product related announcement).
ABDX
UK£0.077
Abingdon Health
7D
-3.1%
1Y
6.9%

Lateral Flow Adoption And Digital Diagnostics Will Support A Stronger Long Term Outlook

Catalysts About Abingdon Health Abingdon Health is a contract developer and manufacturer of rapid lateral flow and related diagnostics, with added regulatory and analytical services across human, veterinary, agritech and environmental markets. What are the underlying business or industry changes driving this perspective?
RUA
UK£0.14
RUA Life Sciences
7D
7.5%
1Y
15.2%
CREO
UK£0.13
Creo Medical Group
7D
-5.3%
1Y
3.9%

CREO: Higher Revenue Assumptions And Steady Fair Value Will Support Long Term Upside

Analysts have maintained their price target on Creo Medical Group at £0.70, reflecting updated views on discount rates, revenue growth assumptions and profit margins while keeping the overall fair value level unchanged. Valuation Changes Fair Value: Held steady at £0.70 per share, indicating no change in the overall valuation output.
TSTL
UK£3.88
Tristel
7D
0.6%
1Y
12.3%
EKF
UK£0.24
EKF Diagnostics Holdings
7D
-7.0%
1Y
25.8%
IHC
UK£0.24
Inspiration Healthcare Group
7D
-4.8%
1Y
43.3%
EMVC
UK£0.55
EMV Capital
7D
-4.3%
1Y
34.1%
AMS
UK£1.96
Advanced Medical Solutions Group
7D
2.3%
1Y
-3.6%
NIOX
UK£0.59
NIOX Group
7D
-6.1%
1Y
-3.6%